Search results for "DONATION"

showing 10 items of 120 documents

Oocyte donation outcome after oncological treatment in cancer survivors.

2012

Objective To study reproductive outcome in patients cured of cancer who required oocyte donation (OD) owing to iatrogenic ovarian dysfunction. Design Multicenter, unmatched, retrospective cohorts study. Setting Private, university-affiliated group of clinics. Patient(s) Women treated and cured of cancer (n = 142) who underwent 333 cycles of OD (exposed group) and women without a previous cancer diagnosis (n = 17,844) who underwent 29,778 cycles of OD (unexposed cohort) between January 2000 and January 2012. Intervention(s) Retrospective chart review. Main Outcome Measure(s) Pregnancy, implantation, miscarriage, and ongoing pregnancy rates. Result(s) There were no differences in terms of pre…

Adultmedicine.medical_specialtyPregnancy Ratemedicine.medical_treatmentMiscarriageCohort StudiesPregnancyRisk FactorsNeoplasmsmedicineHumansOvarian DiseasesSurvivorsRetrospective StudiesGynecologyPregnancyChemotherapyOocyte Donationbusiness.industryIncidenceCancer typePregnancy OutcomeObstetrics and GynecologyCancermedicine.diseaseRadiation therapyAbortion SpontaneousCausalityTreatment OutcomeReproductive MedicineSpainOocyte donationOvarian dysfunctionFemalebusinessInfertility FemaleFertility and sterility
researchProduct

Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial

2010

background: An efficient oocyte cryopreservation method is mandatory to establish a successful egg-banking programme. Although there are increasing reports showing good clinical outcomes after oocyte cryopreservation, there is still a lack of large controlled studies evaluating the effectiveness of oocyte cryo-banking. In this study, we aimed to compare the outcome of vitrified-banked oocytes with the gold standard procedure of employing fresh oocytes. methods: A randomized, prospective, triple-blind, single-centre, parallel-group controlled-clinical trial (NCT00785993), including 600 recipients (a ¼ 0.05 and power of 80% for sample-size calculation) selected among 1032 eligible patients fr…

Adultmedicine.medical_specialtyRandomizationPregnancy RateStatistics as TopicPopulationBiologyCryopreservationlaw.inventionAndrologyRandomized controlled trialPregnancylawmedicineHumansEmbryo ImplantationeducationBiological Specimen BanksCryopreservationGynecologyeducation.field_of_studyOocyte DonationRehabilitationPregnancy OutcomeObstetrics and GynecologyOocyte cryopreservationOocyteConfidence intervalPregnancy ratemedicine.anatomical_structureReproductive MedicineOocytesFemaleInfertility FemaleHuman Reproduction
researchProduct

Improved short-term outcomes of kidney transplants in controlled donation after the circulatory determination of death with the use of normothermic r…

2021

Normothermic Regional Perfusion (NRP) allows the in situ perfusion of organs with oxygenated blood in donation after the circulatory determination of death (DCDD). We aimed at evaluating the impact of NRP on the short-term outcomes of kidney transplants in controlled DCDD (cDCDD). This is a multicenter, nationwide, retrospective study comparing cDCDD kidneys obtained with NRP versus the standard rapid recovery (RR) technique. During 2012-2018, 2,302 cDCDD adult kidney transplants were performed in Spain using NRP (n=865) or RR (n=1,437). The study groups differed in donor and recipient age, warm and cold ischemic time and use of ex situ machine perfusion. Transplants in the NRP group were m…

Adultmedicine.medical_specialtyTissue and Organ Procurementdonors and donationdelayed graft function (DGF)graft survivalnephrologyUrologykidney transplantationorgan procurement and allocationRegional perfusion030230 surgery03 medical and health sciences0302 clinical medicineHumansImmunology and AllergyMedicinePharmacology (medical)Retrospective StudiesTransplantationKidneyMachine perfusionorgan perfusion and preservationbusiness.industryGraft SurvivalRetrospective cohort studyOrgan PreservationKidney TransplantationTissue DonorspracticeDelayed Graft FunctionDeathPerfusionmedicine.anatomical_structureclinical researchDonationPropensity score matchingCirculatory systembusinessdonation after circulatory death (DCD)
researchProduct

The follicular hormonal profile in low-responder patients undergoing unstimulated cycles: is it hypoandrogenic?

2012

STUDY QUESTION What is the final hormonal milieu of pre-ovulatory follicles of low-responder (LR) patients undergoing unstimulated cycles? SUMMARY ANSWER Neither androgen secretion nor LH was impaired in pre-ovulatory follicles of LR women. WHAT IS KNOWN ALREADY Therapies currently used to improve ovarian response in LR women have an impact on the final hormonal follicular milieu, and these changes are believed to be partially responsible for determining the success rate in these women. Surprisingly, as far as we know, there is no report of the final hormonal profile of LR women undergoing unstimulated cycles or evidence that follicular androgen secretion in LR women is impaired. STUDY DESI…

Adultmedicine.medical_specialtymedicine.drug_classDrug ResistanceFertilization in VitroSpindle ApparatusBiologyOvarian FollicleOvulation InductionInternal medicineFollicular phasemedicineHumansProspective StudiesOvarian follicleTestosterone CongenersMetaphaseProgesteroneTestosteroneOocyte DonationRehabilitationAge FactorsObstetrics and GynecologyFertility Agents FemaleLuteinizing HormoneAntral follicleAndrogenFollicular fluidFollicular FluidAndrogen secretionEndocrinologymedicine.anatomical_structureFollicular PhaseReproductive MedicineCase-Control StudiesOocytesFemaleFollicle Stimulating HormoneInfertility FemaleHormoneHuman Reproduction
researchProduct

Genetic polymorphisms of serotonin transporter and receptor 1A could influence success during embryo implantation and maintenance of pregnancy

2012

Objective To explore whether serotonin-related gene polymorphisms influence clinical outcomes of IVF treatment in recipients using donated oocytes. Design Nested case-control study. Setting University-affiliated infertility clinic. Patient(s) Two hundred forty-five women undergoing IVF treatment with donated oocytes. Intervention(s) None. Main Outcome Measure(s) Genotype and haplotype analysis of the serotonin transporter-linked polymorphic region (5-HTTLPR), rs1800532, rs6295, rs6313, and rs3813929, between recipients grouped according to the results of the oocyte donation for IVF treatment. Result(s) No differences were found between genotype distribution of the tryptophan hydroxylase 1, …

Adultmedicine.medical_specialtymedicine.medical_treatmentEarly Pregnancy LossFertilization in VitroPolymorphism Single NucleotideAndrologyGene FrequencyPregnancyRisk FactorsInternal medicineGenotypeOdds RatiomedicineHumansEmbryo ImplantationSerotonin transporterSerotonin Plasma Membrane Transport ProteinsAnalysis of VariancePregnancyChi-Square DistributionIn vitro fertilisationOocyte DonationbiologyHaplotypeObstetrics and GynecologyEmbryo Transfermedicine.diseaseEmbryo transferAbortion SpontaneousPregnancy rateLogistic ModelsPhenotypeTreatment OutcomeEndocrinologyHaplotypesReproductive MedicineCase-Control StudiesReceptor Serotonin 5-HT1Abiology.proteinFemaleFertility and Sterility
researchProduct

Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilizat…

2007

To verify whether the antral follicle count (AFC) could predict ovarian response, oocyte/embryo quality, and IVF outcome.Prospective study.Instituto Universitario-Instituto Valenciano de Infertilidad, Valencia, Spain.One thousand seventy-four donors and 975 oocyte recipient cycles.Controlled ovarian hyperstimulation (COH), endometrial preparation, IVF/intracytoplasmic sperm injection, ET.COH and oocyte/embryo quality parameters and IVF outcome.We observed lower E(2) levels and fewer mature retrieved oocyte numbers among donors who showed an AFC that was10. These donors also showed significantly higher cancellation and no-donation rates; poor and/or insufficient response was the principal ca…

Adultmedicine.medical_specialtymedicine.medical_treatmentEmbryonic DevelopmentOocyte RetrievalCell CountFertilization in VitroControlled ovarian hyperstimulationIntracytoplasmic sperm injectionAndrologyYoung AdultEgg donationOvarian FollicleEmbryo cryopreservationPredictive Value of TestsPregnancymedicineHumansUltrasonographyGynecologyIn vitro fertilisationOocyte Donationbusiness.industryPatient SelectionOvaryPregnancy OutcomeObstetrics and GynecologyFertility Agents FemaleEmbryo MammalianAntral follicleEmbryo transferReproductive MedicineSpainFertilizationVaginaembryonic structuresOocytesFemaleLeuprolidebusinessGonadotropinsEmbryo qualityFertility and Sterility
researchProduct

GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study.

2009

The use of gonadotrophin-releasing hormone (GnRH) agonists for triggering ovulation remains controversial. The primary objective of this study was to evaluate the incidence of ovarian hyperstimulation syndrome (OHSS) following GnRH agonist versus recombinant human chorionic gonadotrophin (HCG) as methods for triggering ovulation. A second aim was to compare the clinical outcome and embryo quality according to the two procedures. The cycle characteristics of 100 oocyte donors undergoing ovarian stimulation and IVF outcomes of their 100 oocyte recipients were analysed. Donors were prospectively randomized into two groups on the last day of ovarian stimulation: Group I received a single bolus …

AgonistAdultendocrine systemmedicine.medical_specialtyAdolescentmedicine.drug_classmedicine.medical_treatmentmedia_common.quotation_subjectOvarian hyperstimulation syndromeFertilization in VitroChorionic GonadotropinAndrologyGonadotropin-Releasing HormoneOvarian Hyperstimulation SyndromeOvulation InductionPregnancymedicineHumansOvulationmedia_commonGynecologyPregnancyIn vitro fertilisationTriptorelin PamoateOocyte Donationbusiness.industryObstetrics and GynecologyOocytemedicine.diseaseTriptorelinRecombinant Proteinsmedicine.anatomical_structureTreatment OutcomeReproductive MedicineFemalebusinesshormones hormone substitutes and hormone antagonistsEmbryo qualityDevelopmental Biologymedicine.drugReproductive biomedicine online
researchProduct

Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist…

2005

Background This descriptive study evaluates the impact on endometrial development of standard and high doses of a GnRH antagonist in stimulated cycles compared with GnRH agonist and natural cycles. Methods Thirty-one oocyte donors were treated with a combination of rFSH and 0.25 mg/day ganirelix (standard dose), 2 mg/day ganirelix (high dose) or 0.6 mg/day buserelin (long protocol). Vaginal progesterone (200 mg/day) was administered in the luteal phase. Endometrial biopsies were performed 2 and 7 days after HCG administration. Additional biopsies were carried out in a subset of 12 subjects, 2 and 7 days following the LH peak of their previous natural cycle. Biopsies were evaluated histologi…

AgonistAdultendocrine systemmedicine.medical_specialtyTime FactorsAdolescentmedicine.drug_classmedicine.medical_treatmentFertilization in VitroLuteal phaseBiologyLuteal PhaseEndometriumBuserelinChorionic GonadotropinGonadotropin-releasing hormone antagonistGonadotropin-Releasing HormoneEndometriumOvulation InductionInternal medicinemedicineHumansUltrasonicsGanirelixOligonucleotide Array Sequence Analysismedicine.diagnostic_testOocyte DonationRehabilitationObstetrics and GynecologyBuserelinmedicine.anatomical_structureEndocrinologyReproductive MedicineGene Expression RegulationReceptors EstrogenMicroscopy Electron ScanningOocytesRNAOvulation inductionFemaleFollicle Stimulating HormoneReceptors Progesteronehormones hormone substitutes and hormone antagonistsmedicine.drugEndometrial biopsyHuman reproduction (Oxford, England)
researchProduct

P-86

2006

Andrologymedicine.medical_specialtyReproductive MedicineObstetricsbusiness.industryPeriod (gene)Oocyte donationmedicineObstetrics and GynecologybusinessFertility and Sterility
researchProduct

Orbital Decomposition of the Carbon Chemical Shielding Tensor in Gold(I) N-Heterocyclic Carbene Complexes.

2020

The good performance of N‐heterocyclic carbenes (NHCs), in terms of versatility and selectivity, has called the attention of experimentalists and theoreticians attempting to understand their electronic properties. Analyses of the Au(I)–C bond in [(NHC)AuL]+/0 (L stands for a neutral or negatively charged ligand), through the Dewar–Chatt–Duncanson model and the charge displacement function, have revealed that NHC is not purely a σ‐donor but may have a significant π‐acceptor character. It turns out, however, that only the σ‐donation bonding component strongly correlates with one specific component of the chemical shielding tensor. Here, in extension to earlier works, a current density analysi…

C-13 NMR-SPECTROSCOPYElectronic structureRING CURRENTS010402 general chemistry01 natural sciencesInorganic Chemistrychemistry.chemical_compoundDONATION Author InformationGROUP-11MAGNETIC-PROPERTIESTensorGold(I) NHC ComplexesFull Paper010405 organic chemistryChemistryLigandElectron donationCAPTIVE INTERMEDIATEFull PapersSymmetry (physics)0104 chemical sciencesChemical shielding tensorChemistryChemical physicsElectron back‐donationElectromagnetic shieldingElectron back-donationPATTERNSDiamagnetismDONATIONGoldCarbeneCurrent densityCarbene ligandsCONTINUOUS TRANSFORMATIONBONDAPPROXIMATIONEuropean journal of inorganic chemistry
researchProduct